Related Experiment Video
Updated: Jun 20, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell
Robin J Prestwich1, Fiona Errington, Lynette P Steele
1Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom;
Abstract:
Oncolytic virotherapy may mediate antitumor effects via direct oncolysis or immune-mediated tumor regression. Although the ability of oncolytic viruses to generate adaptive antitumor immunity has been characterized, their interactions with the innate immune system are relatively unclear. Using a human in vitro system, this study investigates the innate immunological consequences of reovirus therapy and its potential to activate NK cell-mediated antitumor activity. Dendritic cells (DC) loaded with reovirus-infected human melanoma Mel888 cells (DC-MelReo), but not reovirus-infected tumor cells alone, induced IFN-gamma production within the NK cell population upon coculture with PBMC, in a cell-to-cell contact-dependent manner. DC-MelReo secreted the chemokines CCL2, 3, 4, 5, 7, 8, 11, and CXCL10; these culture supernatants induced NK cell chemotaxis. Coculture of DC-MelReo with purified NK cells induced reciprocal contact-dependent phenotypic DC maturation, while DC-MelReo elicited up-regulation of the activation marker CD69 on NK cells, in a partially contact and partially IL-12 dependent manner. Significantly, DC-MelReo induced NK cell cytotoxicity toward tumor cells by a type I IFN dependent mechanism. These data demonstrate that tumor infection by reovirus can act via DC to induce NK cell recruitment, activation, and cytotoxicity, along with reciprocal DC maturation. These findings suggest that reciprocal DC-NK cell interactions, following reovirus therapy, may play an important role in altering the immune milieu of the tumor microenvironment and mediating tumor regression.
Insights
Reovirus therapy activates dendritic cells (DCs) to recruit and activate natural killer (NK) cells, enhancing antitumor immunity. This study reveals how reovirus-infected tumor cells stimulate DCs, leading to robust NK cell-mediated tumor cell killing.
Area of Science:
- Immunology
- Virology
- Cancer Therapy
Background:
- Oncolytic virotherapy uses viruses to fight cancer, but its impact on the innate immune system is not fully understood.
- Reovirus therapy's ability to generate adaptive antitumor immunity is known, yet its innate immune interactions require further investigation.
Purpose of the Study:
- To investigate the innate immunological effects of reovirus therapy using a human in vitro system.
- To explore the potential of reovirus therapy to activate natural killer (NK) cell-mediated antitumor activity.
Main Methods:
- Utilized a human in vitro system involving dendritic cells (DCs) loaded with reovirus-infected melanoma cells (DC-MelReo).
- Co-cultured DC-MelReo with peripheral blood mononuclear cells (PBMCs) and purified NK cells to assess immune responses.
- Measured cytokine production, chemokine secretion, cell-to-cell contact-dependent interactions, and NK cell activation markers (CD69).
Main Results:
- DC-MelReo induced IFN-gamma production in NK cells and secreted chemokines (CCL2, 3, 4, 5, 7, 8, 11, CXCL10) that promoted NK cell chemotaxis.
- Reciprocal DC maturation and NK cell activation (CD69 up-regulation) occurred upon co-culture, dependent on cell contact and IL-12.
- DC-MelReo treatment led to type I IFN-dependent NK cell cytotoxicity against tumor cells.
Conclusions:
- Reovirus infection of tumor cells can activate DCs, which in turn recruit, activate, and enhance NK cell cytotoxicity.
- Reciprocal interactions between DCs and NK cells following reovirus therapy may significantly alter the tumor microenvironment.
- These DC-NK cell interactions are crucial for mediating tumor regression in oncolytic virotherapy.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
